New Key Statistics Module, Z-Score and F-Score
NAS:RNAC Key Ratios
| Market Cap $ M | 455.18 |
| Enterprise Value $ M | 250.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 577.74 |
| Price/Sales | 3.92 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 47.00 |
| EPS (TTM) $ | -54.95 |
| Beneish M-Score | 3.01 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.95 |
| EV-to-EBITDA | -0.95 |
| PEG | -- |
| Shares Outstanding M | 25.41 |
| Net Margin (%) | -510.72 |
| Operating Margin % | -111.60 |
| Pre-tax Margin (%) | -550.36 |
| Quick Ratio | 10.70 |
| Current Ratio | 10.70 |
| ROA % (ttm) | -79.52 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -24.56 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.76 |
RNAC Number of Guru Trades
RNAC Volume of Guru Trades
Gurus Latest Trades with NAS:RNAC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RNAC is held by these investors
Total 1
Cartesian Therapeutics Inc Insider Transactions
No Available Data
News about NAS:RNAC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers